https://www.selleckchem.com/pr....oducts/prt062607-p50
Breast cancer is one of the most frequently diagnosed cancers among women worldwide. Alterations in the tumor microenvironment (TME) have been increasingly recognized as key in the development and progression of breast cancer in recent years. To deeply comprehend the gene expression profiling of the TME and identify immunological targets, as well as determine the relationship between gene expression and different prognoses is highly critical. The stromal/immune scores of breast cancer patients from The Cancer Genome Atlas
Like
Comment
Share
